North America Cell Culture Market worth USD 20.38 billion by 2030
The report "North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030" is projected to reach USD 20.38 billion by 2030 from USD 11.86 billion in 2025, at a CAGR of 11.4% during the forecast period of 2025 to 2030.
Browse 350 market data Tables and 40 Figures spread through 300 Pages and in-depth TOC on "North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-cell-culture-market-26603637.html
Several factors are driving the development of the cell culture market in North America. Among the main drivers of growth is the region's extensive research base, which maintains a high daily demand for media, sera, reagents, and plastics. Biopharmaceutical manufacturing is a major factor, as vaccines and biologics require a stable, high-volume cell culture supply. At the same time, the FDA's initiative to phase out animal testing is leading to increased use of cell-based and organoid-type assays, which in turn increases demand for advanced media and 3D culture ??????reagents.
The consumables segment accounted for the dominant share in 2024 of the North America cell culture market, by product.
By product, the cell culture market in North America is divided into consumables and equipment. In 2024, the consumables segment held the largest revenue share, underscoring their indispensable role in standard research culture as well as in large-scale biopharmaceutical production. Among the components, media, feeds, and single-use disposables are the major contributors to spending because they are the most frequently purchased, recurring items necessary for keeping cells alive, enhancing productivity, and supporting reproducible workflows in academic laboratories, CROs/CDMOs, and biomanufacturing facilities in the ??????region.
The pharmaceutical and biotechnology segment dominated the market in 2024.
By end user, the market is segmented into academic institutions, research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and other end users. Pharmaceutical and biotechnology companies held the largest share in 2024, driven by their extensive use of cell culture in biopharmaceutical production and process development. In this segment, considerable amounts of media, feeds, supplements, and single-use consumables are purchased to support routine manufacturing campaigns and scale-up programs from clinical to commercial ??????supply.
The US is expected to be the fastest-growing region in the North America cell culture market during the forecast period.
By country, the North America cell culture market is divided into the US and Canada. The US holds the largest share and is also growing at the fastest rate due to the rapid expansion of biomanufacturing activity on a large scale. Strong federal support to advance US biotechnology and biomanufacturing is reinforcing new capacity and supply-chain resilience. This directly increases demand for cell culture media, feeds, and high-use single-use consumables across biologics and vaccines.
Key companies active in the North America cell culture market include Thermo Fisher Scientific (US), Sartorius AG (Germany), and Danaher (US), along with other regional and global companies.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the North America Cell Culture Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
